Skip to main content
. 2023 Mar 14;12(9):10280–10293. doi: 10.1002/cam4.5757

FIGURE 2.

FIGURE 2

Overall survival in (A) patients with PD‐L1 CPS ≥10 tumors, (B) patients with PD‐L1 CPS ≥1 tumors, and (C) the intention‐to‐treat population. CPS, combined positive score; HR, hazard ratio; NR, not reached; PD‐L1, programmed cell death ligand 1.